593 related articles for article (PubMed ID: 16636130)
1. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
[TBL] [Abstract][Full Text] [Related]
2. r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans.
Brennan AM; Lee JH; Tsiodras S; Chan JL; Doweiko J; Chimienti SN; Wadhwa SG; Karchmer AW; Mantzoros CS
Eur J Endocrinol; 2009 Feb; 160(2):173-6. PubMed ID: 19029226
[TBL] [Abstract][Full Text] [Related]
3. Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome.
Barb D; Wadhwa SG; Kratzsch J; Gavrila A; Chan JL; Williams CJ; Karchmer AW; Mantzoros CS
J Clin Endocrinol Metab; 2005 Sep; 90(9):5324-8. PubMed ID: 15956078
[TBL] [Abstract][Full Text] [Related]
4. Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study.
Magkos F; Brennan A; Sweeney L; Kang ES; Doweiko J; Karchmer AW; Mantzoros CS
Metabolism; 2011 Jul; 60(7):1045-9. PubMed ID: 21081243
[TBL] [Abstract][Full Text] [Related]
5. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.
Addy CL; Gavrila A; Tsiodras S; Brodovicz K; Karchmer AW; Mantzoros CS
J Clin Endocrinol Metab; 2003 Feb; 88(2):627-36. PubMed ID: 12574192
[TBL] [Abstract][Full Text] [Related]
6. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
Antivir Ther; 2003 Jun; 8(3):199-207. PubMed ID: 12924536
[TBL] [Abstract][Full Text] [Related]
8. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P
Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
[TBL] [Abstract][Full Text] [Related]
9. [Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases].
Tao MM; Zhang L; Qiu ZF; Xie J; Han Y; Yu W; Li M; Li TS
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):867-71. PubMed ID: 19671283
[TBL] [Abstract][Full Text] [Related]
10. Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.
Sutinen J; Walker UA; Sevastianova K; Klinker H; Häkkinen AM; Ristola M; Yki-Järvinen H
Antivir Ther; 2007; 12(1):97-105. PubMed ID: 17503753
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity.
Chan JL; Wong SL; Mantzoros CS
Clin Pharmacokinet; 2008; 47(11):753-64. PubMed ID: 18840030
[TBL] [Abstract][Full Text] [Related]
12. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.
Mulligan K; Khatami H; Schwarz JM; Sakkas GK; DePaoli AM; Tai VW; Wen MJ; Lee GA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2009 Apr; 94(4):1137-44. PubMed ID: 19174500
[TBL] [Abstract][Full Text] [Related]
13. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).
Schindler K; Rieger A; Tura A; Gmeinhardt B; Touzeau-Römer V; Haider D; Pacini G; Ludvik B
Horm Metab Res; 2009 Jul; 41(7):573-9. PubMed ID: 19322744
[TBL] [Abstract][Full Text] [Related]
14. Circulating melanin-concentrating hormone, agouti-related protein, and alpha-melanocyte-stimulating hormone levels in relation to body composition: alterations in response to food deprivation and recombinant human leptin administration.
Gavrila A; Chan JL; Miller LC; Heist K; Yiannakouris N; Mantzoros CS
J Clin Endocrinol Metab; 2005 Feb; 90(2):1047-54. PubMed ID: 15546902
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
16. Effects of fish oil on lipid profile and other metabolic outcomes in HIV-infected patients on antiretroviral therapy: a randomized placebo-controlled trial.
Oliveira JM; Rondó PH; Yudkin JS; Souza JM; Pereira TN; Catalani AW; Picone CM; Segurado AA
Int J STD AIDS; 2014 Feb; 25(2):96-104. PubMed ID: 24285599
[TBL] [Abstract][Full Text] [Related]
17. Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome.
Verkauskiene R; Dollfus C; Levine M; Faye A; Deghmoun S; Houang M; Chevenne D; Bresson JL; Blanche S; Lévy-Marchal C
Pediatr Res; 2006 Aug; 60(2):225-30. PubMed ID: 16864709
[TBL] [Abstract][Full Text] [Related]
18. Leptin in congenital and HIV-associated lipodystrophy.
Tsoukas MA; Farr OM; Mantzoros CS
Metabolism; 2015 Jan; 64(1):47-59. PubMed ID: 25267014
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte-derived hormone levels in HIV lipodystrophy.
Kosmiski L; Kuritzkes D; Lichtenstein K; Eckel R
Antivir Ther; 2003 Feb; 8(1):9-15. PubMed ID: 12713059
[TBL] [Abstract][Full Text] [Related]
20. Adipokines in the HIV/HAART-associated lipodystrophy syndrome.
Paruthi J; Gill N; Mantzoros CS
Metabolism; 2013 Sep; 62(9):1199-205. PubMed ID: 23706880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
